BMO Capital Markets Cuts Prestige Consumer Healthcare (NYSE:PBH) Price Target to $117.00

Prestige Consumer Healthcare (NYSE:PBH – Free Report) had its target price trimmed by BMO Capital Markets from $124.00 to $117.00 in a research report released on Wednesday morning, Benzinga reports. The brokerage currently has an outperform rating on the stock. Several other brokerages also recently commented on PBH. StockNews.com downgraded shares of Prestige Consumer Healthcare […]

Leave a Reply

Your email address will not be published.

Previous post QuickLogic (NASDAQ:QUIK) PT Raised to $12.00 at Oppenheimer
Next post Getty Images (NYSE:GETY) PT Lowered to $7.00